A new study suggests a link, but experts caution that there’s more to the story. By Alisha Haridasani Gupta July 10, 2023 A large new study in Denmark suggested that hormone therapy — which women use to manage menopausal symptoms — was associated with an increased risk of developing Alzheimer’s disease and other types of dementia. …
Do Hormone Treatments for Menopause Increase Dementia Risk? Read More »
Jan 25, 2023 Leah Kuntz SPL026 with supportive therapy sees positive results in patients with major depressive disorder. metamorworks/AdobeStock In the first placebo-controlled efficacy study completed to date exploring a short-duration psychedelic for depression, intravenous (IV) N,N-Dimethyltryptamine (DMT)—SPL026—with supportive therapy for the treatment of major depressive disorder (MDD), met the primary endpoint and demonstrated a …
Positive Results from Phase 2a Trial of Psychedelic for Major Depressive Disorder Read More »
Managing Depression as an Inflammatory Condition Lylen Ferris, ND | March 17, 2021 Patients with major depression have been found to exhibit increased peripheral blood inflammatory biomarkers, including inflammatory cytokines. Cytokines have been shown to access the brain and interact with virtually every pathophysiologic domain known to be involved in depression, including neurotransmitter synthesis and metabolism, neuroendocrine function, and neural plasticity. A …
Managing Depression as an Inflammatory Condition Read More »
By popular demand, Researched Nutritionals is hosting patient webinars focusing on the topics above. Each webinar will air at two times, 3PM and 6PM Pacific. You may register for both times if you would like the option of attending either time slot. Questions may be submitted anytime during the webinar. Dr Hamilton will …
